Stocklytics Platform
Asset logo for symbol PBH
Prestige Consumer Healthcare
PBH61
$85.01arrow_drop_up0.69%$0.59
Asset logo for symbol PBH
PBH61

$85.01

arrow_drop_up0.69%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Prestige Consumer Healthcare (PBH) Stocklytics Forecast

Prestige Consumer Healthcare Inc (PBH) is a well-known player in the healthcare industry. The company specializes in providing over-the-counter healthcare products to consumers. With a strong portfolio of brands and a solid reputation, PBH has been able to establish a significant presence in the market. But what does the future hold for PBH and its stock price?
Predicting stock prices is always a challenging task, but with the help of advanced technologies like artificial intelligence and machine learning, analysts can make more accurate forecasts. While it is impossible to predict the exact stock price of PBH in the future, analysts have made some predictions based on various factors.
add Prestige Consumer Healthcare to watchlist

Keep an eye on Prestige Consumer Healthcare

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Prestige Consumer Healthcare (PBH) stock?

Analysts have set a target price of $64.12 for Prestige Consumer Healthcare (PBH), based on forecasts from 17 analysts. The predicted price range extends from a high of $104 to a low of $43. This represents a potential increase of up to 22.34% and a decrease of -49.42% from the current price of $85.01. These forecasts are as of 2017 May 22.
help

What are the analyst ratings for Prestige Consumer Healthcare (PBH) stock?

Currently, there are no analyst ratings available for Prestige Consumer Healthcare (PBH), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Prestige Consumer Healthcare (PBH) stock?

At present, there is no AI or machine-learning-based price prediction available for Prestige Consumer Healthcare (PBH) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level